SCHEMBL2947602

SCHEMBL2947602

OCCCCC#Cc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.58
CYP3A4 P08684 3/20 0.58
CYP2C9 P11712 3/20 0.58
CYP2C19 P33261 3/20 0.58
ALDH1A1 P00352 2/20 0.58
MAPT P10636 2/20 0.58
KDM4E B2RXH2 2/20 0.58
THPO P40225 1/20 0.48
HTR2C P28335 2/20 0.48
HTR2B P41595 2/20 0.48
BLM P54132 1/20 0.47
PMP22 Q01453 1/20 0.47
HRH3 Q9Y5N1 1/20 0.44
TSHR P16473 1/20 0.44
APP P05067 1/20 0.44
CHRNB4 P30926 1/20 0.42
CHRNA3 P32297 1/20 0.42
HTR2A P28223 1/20 0.41
FFAR1 O14842 2/20 0.41
FFAR4 Q5NUL3 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4948108 0.98 CYP1A2 (0.56) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL23014997 0.98 CYP1A2 (0.56) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL487310 0.94 CYP1A2 (0.50) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL18452361 0.89 KDM4E (0.53) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL9671501 0.87 KDM4E (0.52) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL18453785 0.87 KDM4E (0.52) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL14251994 0.85 CYP1A2 (0.47) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL5808117 0.85 CYP1A2 (0.54) CYP1A2CYP3A4CYP2C9CYP2C19KDM4E
SCHEMBL23015036 0.84 CYP1A2 (0.44) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL17911731 0.84 CYP1A2 (0.58) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7759370-B2 Sphingosine-1-phosphate (SIP) receptor agonists Praecis Pharmaceuticals (US) 2010-07-20 US disclosed
EP-2046746-A2 CHEMICAL COMPOUNDS Praecis Pharmaceuticals Incorporated (US) 2009-04-15 EP disclosed
US-20080096938-A1 Immunosuppressants for autoimmune diseases such as multiple sclerosis, transplant rejection; sphingosine-1-phosphate (S1P) receptor agonists; (S)-2-Amino-2-(5-(4-(2-(pentyloxy)ethoxy)-3-(trifluoromethyl)phenyl)-1,3,4-thiadiazol-2-yl)propyl dihydrogen phosphate for example PRAECIS PHARMACEUTICALS INCORPORATED (US) 2008-04-24 US disclosed
WO-2008016692-A2 CHEMICAL COMPOUNDS PRAECIS PHARMACEUTICALS INCORPORATED (US) 2008-02-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096938-A1 Immunosuppressants for autoimmune diseases such as multiple sclerosis, transplant rejection; sphingosine-1-phosphate (S1P) receptor agonists; (S)-2-Amino-2-(5-(4-(2-(pentyloxy)ethoxy)-3-(trifluoromethyl)phenyl)-1,3,4-thiadiazol-2-yl)propyl dihydrogen phosphate for example S1PR1, S1PR2, S1PR5 CYP1A2 2411/4885CYP3A4 2522/4885CYP2C9 3206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.